ID   KITM_HUMAN              Reviewed;         265 AA.
AC   O00142; B4DGJ7; B4DZK7; B7ZAB1; E5KNQ5; E9PH08; O15238;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 4.
DT   07-APR-2021, entry version 185.
DE   RecName: Full=Thymidine kinase 2, mitochondrial;
DE            EC=2.7.1.21;
DE   AltName: Full=Mt-TK;
DE   Flags: Precursor;
GN   Name=TK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=9079672; DOI=10.1074/jbc.272.13.8454;
RA   Johansson M., Karlsson A.;
RT   "Cloning of the cDNA and chromosome localization of the gene for human
RT   thymidine kinase 2.";
RL   J. Biol. Chem. 272:8454-8458(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 34-61 (ISOFORM
RP   1), AND CHARACTERIZATION.
RC   TISSUE=Brain;
RX   PubMed=9989599; DOI=10.1016/s0014-5793(98)01711-6;
RA   Wang L., Munch-Petersen B., Herrstroem Sjoeberg A., Hellman U., Bergman T.,
RA   Joernvall H., Eriksson S.;
RT   "Human thymidine kinase 2: molecular cloning and characterisation of the
RT   enzyme activity with antiviral and cytostatic nucleoside substrates.";
RL   FEBS Lett. 443:170-174(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 6), AND SUBUNIT.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W., Mindrinos M.,
RA   Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
RN   [4]
RP   SEQUENCE REVISION.
RA   Wang L.;
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3; 4 AND 5).
RC   TISSUE=Brain, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   VARIANTS MTDPS2 ASN-121 AND ASN-212, FUNCTION, AND CHARACTERIZATION OF
RP   VARIANTS MTDPS2 ASN-121 AND ASN-212.
RX   PubMed=11687801; DOI=10.1038/ng751;
RA   Saada A., Shaag A., Mandel H., Nevo Y., Eriksson S., Elpeleg O.;
RT   "Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion
RT   myopathy.";
RL   Nat. Genet. 29:342-344(2001).
RN   [10]
RP   VARIANTS MTDPS2 MET-53; MET-108 AND ASN-121.
RX   PubMed=12391347; DOI=10.1212/01.wnl.0000028689.93049.9a;
RA   Mancuso M., Salviati L., Sacconi S., Otaegui D., Camano P., Marina A.,
RA   Bacman S., Moraes C.T., Carlo J.R., Garcia M., Garcia-Alvarez M.,
RA   Monzon L., Naini A.B., Hirano M., Bonilla E., Taratuto A.L., DiMauro S.,
RA   Vu T.H.;
RT   "Mitochondrial DNA depletion: mutations in thymidine kinase gene with
RT   myopathy and SMA.";
RL   Neurology 59:1197-1202(2002).
RN   [11]
RP   VARIANTS MTDPS2 MET-108 AND LYS-192, AND CHARACTERIZATION OF VARIANTS
RP   MTDPS2 MET-108 AND LYS-192.
RX   PubMed=15639197; DOI=10.1016/j.ymgme.2004.09.005;
RA   Wang L., Limongelli A., Vila M.R., Carrara F., Zeviani M., Eriksson S.;
RT   "Molecular insight into mitochondrial DNA depletion syndrome in two
RT   patients with novel mutations in the deoxyguanosine kinase and thymidine
RT   kinase 2 genes.";
RL   Mol. Genet. Metab. 84:75-82(2005).
RN   [12]
RP   VARIANTS MTDPS2 MET-64 AND TRP-183.
RX   PubMed=15907288; DOI=10.1016/j.nmd.2005.03.010;
RA   Tulinius M., Moslemi A.-R., Darin N., Holme E., Oldfors A.;
RT   "Novel mutations in the thymidine kinase 2 gene (TK2) associated with fatal
RT   mitochondrial myopathy and mitochondrial DNA depletion.";
RL   Neuromuscul. Disord. 15:412-415(2005).
RN   [13]
RP   INVOLVEMENT IN PEOB3, VARIANTS PEOB3 TRP-183 AND ALA-188, CHARACTERIZATION
RP   OF VARIANTS PEOB3 TRP-183 AND ALA-188, AND SUBUNIT.
RX   PubMed=21937588; DOI=10.1093/hmg/ddr438;
RA   Tyynismaa H., Sun R., Ahola-Erkkilae S., Almusa H., Poeyhoenen R.,
RA   Korpela M., Honkaniemi J., Isohanni P., Paetau A., Wang L., Suomalainen A.;
RT   "Thymidine kinase 2 mutations in autosomal recessive progressive external
RT   ophthalmoplegia with multiple mitochondrial DNA deletions.";
RL   Hum. Mol. Genet. 21:66-75(2012).
RN   [14]
RP   VARIANTS MTDPS2 VAL-117 AND VAL-139.
RX   PubMed=25446393; DOI=10.1016/j.mito.2014.10.007;
RA   Knierim E., Seelow D., Gill E., von Moers A., Schuelke M.;
RT   "Clinical application of whole exome sequencing reveals a novel compound
RT   heterozygous TK2-mutation in two brothers with rapidly progressive combined
RT   muscle-brain atrophy, axonal neuropathy, and status epilepticus.";
RL   Mitochondrion 20:1-6(2015).
CC   -!- FUNCTION: Phosphorylates thymidine, deoxycytidine, and deoxyuridine in
CC       the mitochondrial matrix. In non-replicating cells, where cytosolic
CC       dNTP synthesis is down-regulated, mtDNA synthesis depends solely on TK2
CC       and DGUOK. Widely used as target of antiviral and chemotherapeutic
CC       agents. {ECO:0000269|PubMed:11687801}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + thymidine = ADP + dTMP + H(+); Xref=Rhea:RHEA:19129,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17748, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:63528, ChEBI:CHEBI:456216; EC=2.7.1.21;
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:20843780,
CC       ECO:0000269|PubMed:21937588}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=O00142-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00142-2; Sequence=VSP_003028;
CC       Name=3;
CC         IsoId=O00142-3; Sequence=VSP_043503;
CC       Name=4;
CC         IsoId=O00142-4; Sequence=VSP_044459;
CC       Name=5;
CC         IsoId=O00142-5; Sequence=VSP_054606;
CC       Name=6;
CC         IsoId=O00142-6; Sequence=VSP_058694;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in liver, pancreas, muscle,
CC       and brain.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 2 (MTDPS2) [MIM:609560]:
CC       A disorder due to mitochondrial dysfunction characterized by childhood
CC       onset of muscle weakness associated with depletion of mtDNA in skeletal
CC       muscle. There is wide clinical variability; some patients have onset in
CC       infancy and show a rapidly progressive course with early death due to
CC       respiratory failure, whereas others have later onset of a slowly
CC       progressive myopathy. {ECO:0000269|PubMed:11687801,
CC       ECO:0000269|PubMed:12391347, ECO:0000269|PubMed:15639197,
CC       ECO:0000269|PubMed:15907288, ECO:0000269|PubMed:25446393}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA
CC       deletions, autosomal recessive 3 (PEOB3) [MIM:617069]: A form of
CC       progressive external ophthalmoplegia, a mitochondrial myopathy
CC       characterized by progressive paralysis of the levator palpebrae,
CC       orbicularis oculi, and extraocular muscles. PEOB3 patients manifest
CC       adult-onset progressive external ophthalmoplegia and progressive
CC       proximal muscle weakness associated with muscle atrophy.
CC       {ECO:0000269|PubMed:21937588}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DCK/DGK family.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U77088; AAC51167.1; -; mRNA.
DR   EMBL; Y10498; CAA71523.3; -; mRNA.
DR   EMBL; AK294627; BAG57808.1; -; mRNA.
DR   EMBL; AK302976; BAG64119.1; -; mRNA.
DR   EMBL; AK316226; BAH14597.1; -; mRNA.
DR   EMBL; AC010542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471092; EAW83013.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW83015.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW83017.1; -; Genomic_DNA.
DR   EMBL; HQ205385; ADP90853.1; -; Genomic_DNA.
DR   EMBL; HQ205382; ADP90850.1; -; Genomic_DNA.
DR   EMBL; HQ205383; ADP90851.1; -; Genomic_DNA.
DR   EMBL; HQ205384; ADP90852.1; -; Genomic_DNA.
DR   EMBL; HQ205381; ADP90849.1; -; Genomic_DNA.
DR   EMBL; HQ205380; ADP90848.1; -; Genomic_DNA.
DR   EMBL; HQ205379; ADP90847.1; -; Genomic_DNA.
DR   EMBL; HQ205378; ADP90846.1; -; Genomic_DNA.
DR   EMBL; HQ205377; ADP90845.1; -; Genomic_DNA.
DR   EMBL; HQ205376; ADP90844.1; -; Genomic_DNA.
DR   EMBL; HQ205375; ADP90843.1; -; Genomic_DNA.
DR   EMBL; HQ205374; ADP90842.1; -; Genomic_DNA.
DR   EMBL; HQ205373; ADP90841.1; -; Genomic_DNA.
DR   EMBL; HQ205372; ADP90840.1; -; Genomic_DNA.
DR   EMBL; HQ205371; ADP90839.1; -; Genomic_DNA.
DR   EMBL; HQ205370; ADP90838.1; -; Genomic_DNA.
DR   EMBL; HQ205362; ADP90830.1; -; Genomic_DNA.
DR   EMBL; HQ205363; ADP90831.1; -; Genomic_DNA.
DR   EMBL; HQ205364; ADP90832.1; -; Genomic_DNA.
DR   EMBL; HQ205365; ADP90833.1; -; Genomic_DNA.
DR   EMBL; HQ205366; ADP90834.1; -; Genomic_DNA.
DR   EMBL; HQ205367; ADP90835.1; -; Genomic_DNA.
DR   EMBL; HQ205368; ADP90836.1; -; Genomic_DNA.
DR   EMBL; HQ205369; ADP90837.1; -; Genomic_DNA.
DR   EMBL; HQ205346; ADP90814.1; -; Genomic_DNA.
DR   EMBL; HQ205347; ADP90815.1; -; Genomic_DNA.
DR   EMBL; HQ205348; ADP90816.1; -; Genomic_DNA.
DR   EMBL; HQ205349; ADP90817.1; -; Genomic_DNA.
DR   EMBL; HQ205350; ADP90818.1; -; Genomic_DNA.
DR   EMBL; HQ205351; ADP90819.1; -; Genomic_DNA.
DR   EMBL; HQ205352; ADP90820.1; -; Genomic_DNA.
DR   EMBL; HQ205353; ADP90821.1; -; Genomic_DNA.
DR   EMBL; HQ205354; ADP90822.1; -; Genomic_DNA.
DR   EMBL; HQ205355; ADP90823.1; -; Genomic_DNA.
DR   EMBL; HQ205356; ADP90824.1; -; Genomic_DNA.
DR   EMBL; HQ205357; ADP90825.1; -; Genomic_DNA.
DR   EMBL; HQ205358; ADP90826.1; -; Genomic_DNA.
DR   EMBL; HQ205359; ADP90827.1; -; Genomic_DNA.
DR   EMBL; HQ205360; ADP90828.1; -; Genomic_DNA.
DR   EMBL; HQ205361; ADP90829.1; -; Genomic_DNA.
DR   CCDS; CCDS10805.2; -. [O00142-1]
DR   CCDS; CCDS54016.1; -. [O00142-3]
DR   CCDS; CCDS54017.1; -. [O00142-4]
DR   CCDS; CCDS54018.1; -. [O00142-2]
DR   CCDS; CCDS61955.1; -. [O00142-5]
DR   RefSeq; NP_001166114.1; NM_001172643.1. [O00142-2]
DR   RefSeq; NP_001166115.1; NM_001172644.1. [O00142-3]
DR   RefSeq; NP_001258864.1; NM_001271935.1.
DR   RefSeq; NP_001258979.1; NM_001272050.1. [O00142-5]
DR   RefSeq; NP_004605.4; NM_004614.4. [O00142-1]
DR   SMR; O00142; -.
DR   BioGRID; 112939; 9.
DR   IntAct; O00142; 4.
DR   STRING; 9606.ENSP00000299697; -.
DR   BindingDB; O00142; -.
DR   ChEMBL; CHEMBL4580; -.
DR   DrugBank; DB02594; 2'-Deoxycytidine.
DR   DrugBank; DB03312; Brivudine.
DR   DrugBank; DB04485; Thymidine.
DR   DrugBank; DB02452; Thymidine 5'-triphosphate.
DR   DrugCentral; O00142; -.
DR   iPTMnet; O00142; -.
DR   PhosphoSitePlus; O00142; -.
DR   BioMuta; TK2; -.
DR   jPOST; O00142; -.
DR   MassIVE; O00142; -.
DR   MaxQB; O00142; -.
DR   PaxDb; O00142; -.
DR   PeptideAtlas; O00142; -.
DR   PRIDE; O00142; -.
DR   ProteomicsDB; 20434; -.
DR   ProteomicsDB; 47731; -. [O00142-1]
DR   ProteomicsDB; 47732; -. [O00142-2]
DR   ProteomicsDB; 47733; -. [O00142-3]
DR   ProteomicsDB; 5605; -.
DR   Antibodypedia; 29252; 67 antibodies.
DR   Ensembl; ENST00000417693; ENSP00000407469; ENSG00000166548. [O00142-4]
DR   Ensembl; ENST00000451102; ENSP00000414334; ENSG00000166548. [O00142-2]
DR   Ensembl; ENST00000525974; ENSP00000434594; ENSG00000166548. [O00142-5]
DR   Ensembl; ENST00000527800; ENSP00000433770; ENSG00000166548. [O00142-5]
DR   Ensembl; ENST00000544898; ENSP00000440898; ENSG00000166548. [O00142-1]
DR   Ensembl; ENST00000545043; ENSP00000438143; ENSG00000166548. [O00142-3]
DR   Ensembl; ENST00000563369; ENSP00000463560; ENSG00000166548. [O00142-5]
DR   Ensembl; ENST00000677420; ENSP00000504648; ENSG00000166548. [O00142-5]
DR   Ensembl; ENST00000677555; ENSP00000503331; ENSG00000166548. [O00142-5]
DR   Ensembl; ENST00000677715; ENSP00000502950; ENSG00000166548. [O00142-5]
DR   Ensembl; ENST00000678015; ENSP00000502959; ENSG00000166548. [O00142-5]
DR   Ensembl; ENST00000678297; ENSP00000503472; ENSG00000166548. [O00142-5]
DR   GeneID; 7084; -.
DR   KEGG; hsa:7084; -.
DR   UCSC; uc002eor.4; human. [O00142-1]
DR   UCSC; uc059vic.1; human.
DR   CTD; 7084; -.
DR   DisGeNET; 7084; -.
DR   GeneCards; TK2; -.
DR   GeneReviews; TK2; -.
DR   HGNC; HGNC:11831; TK2.
DR   HPA; ENSG00000166548; Low tissue specificity.
DR   MalaCards; TK2; -.
DR   MIM; 188250; gene.
DR   MIM; 609560; phenotype.
DR   MIM; 617069; phenotype.
DR   neXtProt; NX_O00142; -.
DR   OpenTargets; ENSG00000166548; -.
DR   Orphanet; 254886; Autosomal recessive progressive external ophthalmoplegia.
DR   Orphanet; 254875; Mitochondrial DNA depletion syndrome, myopathic form.
DR   PharmGKB; PA36535; -.
DR   VEuPathDB; HostDB:ENSG00000166548.15; -.
DR   eggNOG; KOG4235; Eukaryota.
DR   GeneTree; ENSGT00940000158005; -.
DR   HOGENOM; CLU_030466_1_0_1; -.
DR   InParanoid; O00142; -.
DR   OMA; IFAKYLH; -.
DR   PhylomeDB; O00142; -.
DR   TreeFam; TF324413; -.
DR   BioCyc; MetaCyc:HS09420-MONOMER; -.
DR   BRENDA; 2.7.1.21; 2681.
DR   PathwayCommons; O00142; -.
DR   Reactome; R-HSA-73614; Pyrimidine salvage.
DR   SABIO-RK; O00142; -.
DR   BioGRID-ORCS; 7084; 5 hits in 997 CRISPR screens.
DR   ChiTaRS; TK2; human.
DR   GenomeRNAi; 7084; -.
DR   Pharos; O00142; Tchem.
DR   PRO; PR:O00142; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; O00142; protein.
DR   Bgee; ENSG00000166548; Expressed in testis and 223 other tissues.
DR   ExpressionAtlas; O00142; baseline and differential.
DR   Genevisible; O00142; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019136; F:deoxynucleoside kinase activity; IBA:GO_Central.
DR   GO; GO:0004797; F:thymidine kinase activity; TAS:ProtInc.
DR   GO; GO:0071897; P:DNA biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome.
DR   CDD; cd01673; dNK; 1.
DR   InterPro; IPR002624; DCK/DGK.
DR   InterPro; IPR031314; DNK_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF01712; dNK; 1.
DR   PIRSF; PIRSF000705; DNK; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Direct protein sequencing;
KW   Disease variant; DNA synthesis; Kinase; Mitochondrion; Nucleotide-binding;
KW   Primary mitochondrial disease; Progressive external ophthalmoplegia;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT         1..33
FT                   /note="Mitochondrion"
FT   CHAIN           34..265
FT                   /note="Thymidine kinase 2, mitochondrial"
FT                   /id="PRO_0000016842"
FT   NP_BIND         57..65
FT                   /note="ATP"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        133
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255"
FT   BINDING         81
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         99
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         110
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         134
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         201
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..97
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054606"
FT   VAR_SEQ         1..41
FT                   /note="MLLWPLRGWAARALRCFGPGSRGSPASGPGPRRVQRRAWPP -> MGAFCQR
FT                   PSS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9079672"
FT                   /id="VSP_003028"
FT   VAR_SEQ         1
FT                   /note="M -> MRPGLFKGQAPGSRRRPTAGLAVVRADSHKKEPRASGSARPAM (in
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:20843780"
FT                   /id="VSP_058694"
FT   VAR_SEQ         53..77
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043503"
FT   VAR_SEQ         78..95
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044459"
FT   VARIANT         53
FT                   /note="I -> M (in MTDPS2; dbSNP:rs137854432)"
FT                   /evidence="ECO:0000269|PubMed:12391347"
FT                   /id="VAR_019419"
FT   VARIANT         64
FT                   /note="T -> M (in MTDPS2; dbSNP:rs281865487)"
FT                   /evidence="ECO:0000269|PubMed:15907288"
FT                   /id="VAR_023790"
FT   VARIANT         108
FT                   /note="T -> M (in MTDPS2; reduction of activity;
FT                   dbSNP:rs137854431)"
FT                   /evidence="ECO:0000269|PubMed:12391347,
FT                   ECO:0000269|PubMed:15639197"
FT                   /id="VAR_019420"
FT   VARIANT         117
FT                   /note="M -> V (in MTDPS2; severe form of combined brain and
FT                   muscular atrophy; depletion of mtDNA in skeletal muscle;
FT                   normal residual mtDNA in blood and fibroblasts)"
FT                   /evidence="ECO:0000269|PubMed:25446393"
FT                   /id="VAR_072789"
FT   VARIANT         121
FT                   /note="H -> N (in MTDPS2; reduction of activity in muscles;
FT                   dbSNP:rs137854429)"
FT                   /evidence="ECO:0000269|PubMed:11687801,
FT                   ECO:0000269|PubMed:12391347"
FT                   /id="VAR_019421"
FT   VARIANT         139
FT                   /note="A -> V (in MTDPS2; severe form of combined brain and
FT                   muscular atrophy; depletion of mtDNA in skeletal muscle;
FT                   normal residual mtDNA in blood and fibroblasts;
FT                   dbSNP:rs281865494)"
FT                   /evidence="ECO:0000269|PubMed:25446393"
FT                   /id="VAR_072790"
FT   VARIANT         183
FT                   /note="R -> W (in MTDPS2 and PEOB3; reduction of activity;
FT                   reduced affinity for ATP; dbSNP:rs137886900)"
FT                   /evidence="ECO:0000269|PubMed:15907288,
FT                   ECO:0000269|PubMed:21937588"
FT                   /id="VAR_023791"
FT   VARIANT         188
FT                   /note="T -> A (in PEOB3; reduction of activity; reduced
FT                   affinity for ATP; dbSNP:rs281865495)"
FT                   /evidence="ECO:0000269|PubMed:21937588"
FT                   /id="VAR_076984"
FT   VARIANT         192
FT                   /note="R -> K (in MTDPS2; reduction of activity;
FT                   dbSNP:rs281865496)"
FT                   /evidence="ECO:0000269|PubMed:15639197"
FT                   /id="VAR_023792"
FT   VARIANT         212
FT                   /note="I -> N (in MTDPS2; reduction of activity in muscles;
FT                   dbSNP:rs137854430)"
FT                   /evidence="ECO:0000269|PubMed:11687801"
FT                   /id="VAR_019422"
FT   CONFLICT        37
FT                   /note="R -> Y (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        49
FT                   /note="K -> E (in Ref. 5; BAG57808)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        61
FT                   /note="S -> G (in Ref. 1; AAC51167)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        206
FT                   /note="L -> P (in Ref. 5; BAG57808)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        238
FT                   /note="D -> DH (in Ref. 2; CAA71523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        241
FT                   /note="Missing (in Ref. 1; AAC51167)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        251
FT                   /note="N -> S (in Ref. 5; BAG57808)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   265 AA;  31005 MW;  1E9CB62D0321A992 CRC64;
     MLLWPLRGWA ARALRCFGPG SRGSPASGPG PRRVQRRAWP PDKEQEKEKK SVICVEGNIA
     SGKTTCLEFF SNATDVEVLT EPVSKWRNVR GHNPLGLMYH DASRWGLTLQ TYVQLTMLDR
     HTRPQVSSVR LMERSIHSAR YIFVENLYRS GKMPEVDYVV LSEWFDWILR NMDVSVDLIV
     YLRTNPETCY QRLKKRCREE EKVIPLEYLE AIHHLHEEWL IKGSLFPMAA PVLVIEADHH
     MERMLELFEQ NRDRILTPEN RKHCP
//
